Cyclization process step in the making of quinolones and naphthyridines

Details for Australian Patent Application No. 2002229057 (hide)

Owner The Procter & Gamble Company

Inventors Randall, Jared Lynn; Mundla, Sreenivasa Reddy

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2002229057

PCT Pub. Number WO02/48113

Priority 60255633 14.12.00 US

Filing date 7 December 2001

Wipo publication date 24 June 2002

Acceptance publication date 21 April 2005

International Classifications

C07D 215/56 Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 498/06 Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 471/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 513/04 Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

C07D 401/04 Heterocyclic compounds containing two or more hetero rings

Event Publications

21 April 2005 Application Accepted

  Published as AU-B-2002229057

18 August 2005 Standard Patent Sealed

18 February 2010 Assignment Registered

  The Procter & Gamble Company The patent has been assigned to Warner Chilcott Company, LLC

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002229058

2002229056-Methods for treating neuropsychiatric disorders with NMDA receptor antagonists